ArticleCanadian journal of surgery. Journal canadien de chirurgie2006
Delays to surgery in non-small-cell lung cancer.
Article in Canadian journal of surgery. Journal canadien de chirurgie, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Redefining treatment interval in lung cancer surgery in the era of prehabilitation: a systematic review.Translational lung cancer research · 2025Review
- Wait Times and Survival in Lung Cancer Patients across the Province of Quebec, Canada.Current oncology (Toronto, Ont.) · 2022Review
- Wait times in the management of non-small cell lung carcinoma before, during and after regionalization of lung cancer care: a high-resolution analysis.Canadian journal of surgery. Journal canadien de chirurgie · 2021Article
- Systematic Review of Interventions to Reduce Operating Time in Lung Cancer Surgery.Clinical Medicine Insights. Oncology · 2021Review
- Time to surgery in thoracic cancers and prioritization during COVID-19: a systematic review.Journal of thoracic disease · 2020Article
- The impact of concordance with a lung cancer diagnosis pathway guideline on treatment access in patients with stage IV lung cancer.Journal of thoracic disease · 2020Article
- Effect of time interval from diagnosis to treatment for non-small cell lung cancer on survival: a national cohort study in Taiwan.BMJ open · 2020Article
- Article
- Time to treatment and survival in veterans with lung cancer eligible for curative intent therapy.Respiratory medicine · 2018Article
- Impact of rapid investigation clinic on timeliness of lung cancer diagnosis and treatment.BMC pulmonary medicine · 2017Article
- Timeliness of Care and Lung Cancer Tumor-Stage Progression: How Long Can We Wait?The Annals of thoracic surgery · 2017Article
- Lung cancer care trajectory at a Canadian centre: an evaluation of how wait times affect clinical outcomes.Current oncology (Toronto, Ont.) · 2017Article
- Transfer between hospitals as a predictor of delay in diagnosis and treatment of patients with Non-Small Cell Lung Cancer - a register based cohort-study.BMC health services research · 2017Article
- Managing patient pathways to achieve lung cancer waiting time targets: mixed methods study.JRSM short reports · 2012Article
- Cancer diagnostic assessment programs: standards for the organization of care in Ontario.Current oncology (Toronto, Ont.) · 2009Article
- Lung cancer diagnostic and treatment intervals in the United States: a health care disparity?Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2009Article
- Time to treatment in patients with stage III non-small cell lung cancer.International journal of radiation oncology, biology, physics · 2009Article
- A prospective study of peri-diagnostic and surgical wait times for patients with presumptive colorectal, lung, or prostate cancer.British journal of cancer · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn Canada, waiting times for referral and surgery exist for both benign and malignant disease. We attempted to evaluate the length of various waiting times for surgery as well as their association with surgical stage in patients with non-small-cell lung cancer (NSCLC).
methodsThis observational study consisted of a retrospective review of data for all patients who underwent an operation with the intent to cure NSCLC between Jan. 1, 1993, and Dec. 31, 2002, at the Montreal General Hospital, McGill University Health Centre, Montréal, Que. Time intervals between multiple preoperative points and surgery were calculated. The patients were then linked via universal health care insurance numbers with data from the centralized provincial inclusive health care database. This allowed the calculation of the precise interval between the patients' first contact with a physician for symptoms related to their malignancy and surgery. Mean time intervals were then compared with surgical stage.
resultsWe found adequate data for time interval analysis over 10 years for 256 patients who had undergone surgery with intent to cure. The distribution of patients by TNM stage was as follows: stage I, 144 patients (56.3%); stage II, 47 patients (18.4%); stage III, 41 patients (16.0%); and stage IV, 24 patients (9.4%). Mean and median time intervals between initial contact with physician or first onset of symptoms relating to lung cancer and surgery were 208 (standard deviation [SD] 313) days and 109 days, respectively. Mean and median time intervals between initial contact with the thoracic surgeon and surgery were 104 (SD 99) days and 82 days, respectively. No detrimental effect was observed between time to surgery and surgical stage in patients with NSCLC.
conclusionsExcessive preoperative waiting times before attempts at curative surgical resection for NSCLC exist in our centre. These intervals are exceptionally long, multifactorial and cause for concern.
Indexed as
Identifiers
16524140PMC3207511What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.